D-1309-2020 Class II Terminated

Recalled by Hikma Pharmaceuticals USA Inc. — Cherry Hill, NJ

Recall Details

Product Type
Drugs
Report Date
June 24, 2020
Initiation Date
June 11, 2020
Termination Date
June 10, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
17,998 vials

Product Description

Irinotecan HCL Injection, USP, 100mg/5mL, 5 mL vials, Rx only, Manufactured by: Thymoorgan Pharmazie GmbH, Shiffgraben 23, 38690 Golsar, Germany Distributed by: West-Word Pharmaceutical Corp. Eatontown, NJ 07724 USA, NDC 0143-9583-01

Reason for Recall

Defective Container: Customer complaints received of a crimp defect while removing the flip-cap during use.

Distribution Pattern

Nationwide within the United States

Code Information

Lot #:AC0231A, exp. date 08/2021